Home Newsfeeds Keybanc Upgrades Toll Brothers to Sector Weight

Keybanc Upgrades Toll Brothers to Sector Weight

Keybanc analyst Kenneth Zener upgrades Toll Brothers (NYSE:TOL) from Underweight to Sector Weight.

byBenzinga Newsdesk

September 19, 2022

1 minute read

Keybanc analyst Kenneth Zener upgrades Toll Brothers (NYSE:TOL) from Underweight to Sector Weight.

News

Nasdaq Completes Migration Of The First U.S. Options Market To AWS

By Benzinga Newsdesk

December 5, 11:31 AM

The Successful Migration of MRX Marks a Major Milestone in Building the Global Capital Markets Infrastructure of the Future The New Cloud-Enabled Market Infrastructure Delivers a 10% Performance

AMZN

Intrepid Potash Q3 EPS $0.97 Misses $1.74 Estimate, Sales $74.75M Miss $81.49M Estimate

By Benzinga Newsdesk

November 2, 5:03 PM

Intrepid Potash (NYSE:IPI) reported quarterly earnings of $0.97 per share which missed the analyst consensus estimate of $1.74 by 44.25 percent. This is a 223.33 percent increase over earnings of $0.30 per share from the

IPI

Crypto Wallet BitKeep, Hit By $1M Hack, Pledges To Reimburse Affected Users

By Mehab Qureshi

October 18, 4:42 AM

Cryptocurrency wallet BitKeep was hacked on Tuesday, causing a loss of about $1 million, according to the company. BitKeep has promised to fully reimburse users hit by the exploit.

$MATIC

Enlivex Announces Tislelizumab Clinical Collaboration, FY22 Financial Results, And Provides Business Updates; As Of December 31, 2022, Enlivex Had Cash, Cash Equivalents, Short Term Deposits Of $50.2M

By Happy Mohamed

April 4, 8:28 AM

Clinical collaboration with BeiGene announced on April 3, 2023 to evaluate the safety and efficacy of Allocetra™, an investigational macrophage-reprogramming cell therapy, in combination with

ENLV

Keybanc Upgrades Toll Brothers to Sector Weight

Related Posts

Nasdaq Completes Migration Of The First U.S. Options Market To AWS

Intrepid Potash Q3 EPS $0.97 Misses $1.74 Estimate, Sales $74.75M Miss $81.49M Estimate

Crypto Wallet BitKeep, Hit By $1M Hack, Pledges To Reimburse Affected Users

Enlivex Announces Tislelizumab Clinical Collaboration, FY22 Financial Results, And Provides Business Updates; As Of December 31, 2022, Enlivex Had Cash, Cash Equivalents, Short Term Deposits Of $50.2M